| Victoria Templin, | |
|
445 Centennial Ave, Butte, MT 59701-2870 | |
| (406) 723-4075 | |
| Not Available |
| Full Name | Victoria Templin |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 445 Centennial Ave, Butte, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356103485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | BBH-SWLC-LIC-70051 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Victoria Templin, 445 Centennial Ave, Butte, MT 59701-2870 Ph: (406) 723-4075 | Victoria Templin, 445 Centennial Ave, Butte, MT 59701-2870 Ph: (406) 723-4075 |
News Archive
Regular exercise appears to modestly increase levels of high-density lipoprotein, or "good," cholesterol, according to a meta-analysis study in the May 28 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
A new enhanced recovery after surgery process -; also known as ERAS -; has been developed and implemented at the University of Alabama at Birmingham to help enhance a mother's recovery after a cesarean delivery, one of the most common surgeries performed in the United States.
› Verified 3 days ago
Amanda Rose Schmidt, MSW, LCSW, LNHA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 406-723-3225 | |
Monique Paulus, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 Dewey Blvd, Butte, MT 59701 Phone: 858-829-5782 | |
Wendy R Simpson, SWLC, LAC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 65 E Broadway St Ste 102, Butte, MT 59701 Phone: 406-624-9744 | |
Mrs. Traci Lynn Richards, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 106 W Broadway St, Butte, MT 59701 Phone: 406-723-5489 Fax: 406-782-4020 | |
Mary Michelle Morgan, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 81 W Park St, Butte, MT 59701 Phone: 406-497-9047 | |
Mrs. Stephanie I Reichhardt, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 690 S Excelsior Ave, Butte, MT 59701 Phone: 406-491-1439 Fax: 406-299-3772 | |
Ms. Molly M. Molloy, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 55 Basin Creek Rd, Butte, MT 59701 Phone: 406-533-2713 |